We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Serum Metabolite Range Expanded Through Technology

By LabMedica International staff writers
Posted on 16 Mar 2011
Analytical technology has identified numerous blood metabolites in human serum that doctors can potentially look at to diagnose and treat health problems.

The metabolites that can be detected in human serum along with their respective concentrations and disease association have been revealed using a variety of techniques. More...


Scientists at the University of Alberta, (Edmonton, AB, Canada), have analyzed blood components to ascertain the most definitive human-serum metabolome to date. The data also includes chemicals found in the blood plasma. More than 20 scientists at six different institutions used state of the art technology to validate past research. The team also conducted its own laboratory experiments to break new ground on the content of human blood chemistry.

They used the following methods with mass spectroscopy (MS): gas chromatography (GC-MS); thin layer chromatography (TLC/GC-MS), liquid chromatography (LC-MS), ultrahigh performance liquid chromatography (UPLC-MS/MS), and direct flow injection (DFI -MS/MS) to identify, quantify and validate more than 4,000 plasma and serum metabolites. High-resolution nuclear magnetic resonance (NMR) spectroscopy was also used. The human serum metabolome database, created by the scientists is open access, allowing anyone to log on and find the expanded list of blood chemicals. Doctors can now tap into the collected wisdom of hundreds of blood-research projects done in the past by scientists all over the world

David Wishart, PhD, a lead author of the study, said, "Right now a medical doctor analyzing the blood of an ailing patient looks at something like 10 to 20 chemicals. We have identified 4,229 blood chemicals that doctors can potentially look at to diagnose and treat health problems. This is the most complete chemical characterization of blood ever done. We now know the normal values of all the detectable chemicals in blood. Doctors can use these measurements as a reference point for monitoring a patient's current and even future health." The study was published on February 16, 2011, in the journal Public Library of Science, PLoS One.

Related Links:

University of Alberta
The human serum metabolome database


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Blood Ammonia Test Analyzer
DRI-CHEM NX10N
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.